FDA Alert: Raptiva (efalizumab)
Links shared publicly online about this topic.
- 2,245total visits
FDA Alert: Raptiva (efalizumab)
View full resource at drugs.com
Most Recently Shared on February 19, 2009 at 11:44 pm By:
FDA Alert - Raptiva (efalizumab) - http://tinyurl.com/bhdkfx
FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market
usrecallnews.com — “PRESCRIBERS SHOULD IMMEDIATELY BEGIN DISCUSSING WITH PATIENTS CURRENTLY USING RAPTIVA ON HOW TO TRANSITION TO ALTERNATIVE THERAPIES.” View full resource at usrecallnews.com
Most Recently Shared on April 13, 2009 at 1:53 am By:
New Recall Alert: FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market http://tinyurl.com/ccu6lk
Medical News: Raptiva Yanked from U.S. Market - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WHEELING, W.Va. -- The psoriasis drug efalizumab (Raptiva) will be removed from the U.S. market because of the risk of progressive multifocal leukoencephalopathy (PML), its manufacturer said today.” View full resource at medpagetoday.com
Most Recently Shared on April 9, 2009 at 11:42 am By:
Efalizumab Yanked from U.S. Market http://medpagetoday.com/13666
FDA Alert: Raptiva (efalizumab)
drugs.com — “FDA Alert: Raptiva (efalizumab)” View full resource at drugs.com
Most Recently Shared on April 8, 2009 at 11:49 pm By:
FDA Alert - Raptiva (efalizumab) - Genentech and FDA announce voluntary, phased withdrawal of Raptiva - http://tinyurl.com/ddwqf6
Makers of Raptiva Remove Psoriasis Drug From Market Due to PML Risks
usrecallnews.com — “Genentech, makers of the psoriasis drug Raptiva (efalizumab) have announced a voluntary withdrawal of the drug from the US market after learning of a rare but serious risk to patients taking the drug.” View full resource at usrecallnews.com
Most Recently Shared on April 8, 2009 at 10:51 pm By:
New Recall Alert: Makers of Raptiva Remove Psoriasis Drug From Market Due to PML Risks http://tinyurl.com/cant5q
FDA: Psoriasis drug may be linked to 3 deaths* | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The Food and Drug Administration today warned American patients that it is investigating the possibility of a link between the psoriasis drug marketed as Raptiva (efalizumab) and at least three deaths caused by a rare brain infection called progressive multifocal...” View full resource at latimesblogs.latimes.com
Most Recently Shared on February 20, 2009 at 1:10 am By:
LA Times Health News Health News
FDA: Psoriasis drug may be linked to 3 deaths*: The Food and Drug Administration today warned American patients .. http://tinyurl.com/db3t9b
Advertisement
